SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharmaceuticals informs about unaudited financial results

01 Nov 2016 Evaluate

Vista Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 11, 2016, to consider and approve the Unaudited Financial Results of the Company for the quarter/half year ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Vista Pharma Share Price

7.96 0.26 (3.38%)
24-Apr-2026 12:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.50
Dr. Reddys Lab 1321.40
Cipla 1287.20
Zydus Lifesciences 929.85
Lupin 2267.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×